MedPath
HSA Approval

BUPIVACAINE-BAXTER SOLUTION FOR INJECTION 5 MG/ML

SIN15019P

BUPIVACAINE-BAXTER SOLUTION FOR INJECTION 5 MG/ML

BUPIVACAINE-BAXTER SOLUTION FOR INJECTION 5 MG/ML

May 25, 2016

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

EPIDURAL, INFILTRATION

Medical Information

N01BB01

bupivacaine

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Pharmaceuticals India Private Limited

Active Ingredients

Bupivacaine Hydrochloride

5 mg/mL

Bupivacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUPIVACAINE-BAXTER SOLUTION FOR INJECTION 5 MG/ML - HSA Approval | MedPath